Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medical Data Vision Co's Enterprise Value is 円62,028 Mil.
Medical Data Vision Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円720 Mil. Therefore, Medical Data Vision Co's EV-to-FCF for today is 86.17.
The historical rank and industry rank for Medical Data Vision Co's EV-to-FCF or its related term are showing as below:
TSE:3902'
s EV-to-FCF Range Over the Past 10 Years
Min: -1202.13 Med: 43.36 Max: 39757.1
Current: 86.17
During the past 13 years, the highest EV-to-FCF of Medical Data Vision Co was 39757.10. The lowest was -1202.13. And the median was 43.36.
TSE:3902's EV-to-FCF is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 18.62
vs TSE:3902: 86.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Data Vision Co (TSE:3902) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Data Vision Co's PE Ratio (TTM) for today is calculated as:
Medical Data Vision Co's share price for today is 円1684.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Data Vision Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円7.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Medical Data Vision Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's EV-to-FCF falls into.
Medical Data Vision Co's current Enterprise Value is 円62,028 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Data Vision Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円720 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co (TSE:3902) has a EV-to-FCF of 86.17 as of Aug. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Data Vision Co and its competitors. This is 99% above median its historical median of 43.36.
Is Medical Data Vision Co's EV-to-FCF too high?
Medical Data Vision Co's current EV-to-FCF of 86.17 is 99% above median its 10-year median of 43.36. The Healthcare Providers & Services industry median EV-to-FCF is 18.62. Medical Data Vision Co's value of 86.17 is 362.8% above this industry median. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's EV-to-FCF compare to VEEV and TEM?
Medical Data Vision Co's EV-to-FCF of 86.17 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-FCF is 18.62. Medical Data Vision Co's value of 86.17 is 362.8% above this benchmark. While the company's 10-year median is 43.36 vs. the industry median of 18.62, Medical Data Vision Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.62, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Data Vision Co's current EV-to-FCF of 86.17 is 362.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current EV-to-FCF is 86.17, which is 99% above median its own 10-year median of 43.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current EV-to-FCF of 86.17. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current EV-to-FCF is 86.17, which is 99% above median its 10-year median of 43.36 and 362.8% above the Healthcare Providers & Services industry median of 18.62. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current EV-to-FCF is 86.17 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
EV-to-FCF: 86.17 (99% above median its 10-year median of 43.36)
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
Industry Position: 362.8% above the Healthcare Providers & Services median
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
